NIHR Maudsley BRC Blog

Our latest news & events

Latest COVID-19 Vaccine Study in the UK Launches in London

On Wednesday 14th April, the latest COVID-19 vaccine study was launched in London, with the King's Clinical Research Facility being one of the sites taking part. Sponsored by Canadian biopharmaceutical company Medicago and GlaxoSmithKline, the Phase 3 clinical trial will test the safety and efficacy of a plant-derived vaccine candidate named CoVLP.

By NIHR King's Clinical Research Facility at 14 Apr 2021

Novavax confirms vaccine provides 100% protection against severe COVID-19

Final analysis of UK Phase 3 trials of Novavax's COVID-19 vaccine reveals it provides 100% protection against severe COVID-19.

By NIHR Wellcome King's Clinical Research Facility at 16 Mar 2021

Professor Peter Goadsby awarded world’s top Brain Prize 2021

Peter Goadsby, Professor of Neurology at King's College London’s Institute of Psychiatry, Psychology & Neuroscience (IoPPN), and Director at the National Institute for Health Research-Wellcome Trust Clinical Research Facility (NIHR CRF), King's College Hospital has been awarded the world’s top Brain Prize from the Lundbeck Foundation for his pioneering migraine research.

By NIHR Maudsley BRC at 4 Mar 2021

Londoner proud to play his part in COVID-19 fightback by taking part in vaccine trial

A 30-year-old man has spoken about his pride in aiding the national fightback against COVID-19 by taking part in vaccine research in south London.

By NIHR Wellcome King's Clinical Research Facility at 26 Feb 2021

Novavax trial reveals 89.3% effectiveness in preventing COVID-19

Interim analysis of study shows that the NIHR-supported Novavax COVID-19 vaccine is 89.3% effective at preventing COVID-19, including effectiveness against the new variants of concern.

By NIHR Wellcome King's Clinical Research Facility at 29 Jan 2021